Sphingosine-1-phosphate signaling: Unraveling its role as a drug target against infectious diseases

Drug Discovery Today

Volumn 21, Issue 1, 2016, Pages 133-142

  Arish, Mohd ^a   Husein, Atahar ^a   Kashif, Mohammad ^a   Saleem, Mohammed ^b   Akhter, Yusuf ^c   Rub, Abdur ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^c CENTRAL UNIVERSITY OF HIMACHAL PRADESH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 [[4 (4 CHLOROPHENYL) 2 THIAZOLYL]AMINO]PHENOL; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; AAL R; ACYLTRANSFERASE INHIBITOR; ANTIINFLAMMATORY AGENT; CYM 5442; DIMETHYLSPHINGOSINE; ENZYME ANTIBODY; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPASE D; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ALZHEIMER DISEASE; APOPTOSIS; BACTERIAL INFECTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; IMMUNE RESPONSE; INFECTION; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE SCLEROSIS; MYCOSIS; PHAGOLYSOSOME; PROTEIN SECRETION; PROTOZOAL INFECTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION; ANALOGS AND DERIVATIVES; COMMUNICABLE DISEASES; DRUG DELIVERY SYSTEM; DRUG EFFECTS; METABOLISM; PROCEDURES;

ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; DRUG DELIVERY SYSTEMS; LYSOPHOSPHOLIPIDS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84960214021     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.09.013     Document Type: Review

References (84)

1. M. Saleem, and et al. A balance between membrane elasticity and polymerization energy sets the shape of spherical clathrin coats Nat. Commun. 6 2015 6249
2. M. Arish, and et al. Orchestration of membrane receptor signaling by membrane lipids Biochimie 113 2015 111 124
3. Y.A. Hannun, and L.M. Obeid Principles of bioactive lipid signalling: lessons from sphingolipids Nat. Rev. Mol. Cell Biol. 9 2008 139 150
4. H. Fyrst, and J.D. Saba An update on sphingosine-1-phosphate and other sphingolipid mediators Nat. Chem. Biol. 6 2010 489 497
5. G. Schneider, and et al. Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy Mol. Cancer Res. 11 2013 793 807
6. V.C. Tam Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections Semin. Immunol. 25 2013 240 248
7. D.L. Siow, and et al. Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate J. Lipid Res. 51 2010 2546 2559
8. M. Maceyka, and et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism J. Biol. Chem. 280 2005 37118 37129
9. S. Spiegel, and S. Milstien Sphingosine 1-phosphate, a key cell signaling molecule J. Biol. Chem. 277 2002 25851 25854
10. S.M. Mandala Sphingosine-1-phosphate phosphatases Prostaglandins 64 2001 143 156
11. F. Bourquin, and et al. Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism Structure 18 2010 1054 1065
12. Y. Hisano, and et al. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720 J. Biol. Chem. 286 2011 1758 1766
13. Y.M. Lee, and et al. A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC) Prostaglandins Other Lipid Mediat. 84 2007 154 162
14. H. Chi Sphingosine-1-phosphate and immune regulation: trafficking and beyond Trends Pharmacol. Sci. 32 2011 16 24
15. J. Rivera, and et al. The alliance of sphingosine-1-phosphate and its receptors in immunity Nat. Rev. Immunol. 8 2008 753 763
16. Y. Igarashi Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: in regard to membrane sphingolipid signaling pathways J. Biochem. 122 1997 1080 1087
17. M. Fueller, and et al. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate Cell Signal. 15 2003 367 375
18. C.Q. Duong, and et al. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages Biochim. Biophys. Acta 1682 2004 112 119
19. R. Van Doorn, and et al. Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions Glia 58 2010 1465 1476
20. E.E. Donovan, and et al. S1P3 confers differential S1P-induced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development Eur. J. Immunol. 40 2010 688 698
21. I. Fischer, and et al. Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions PLoS ONE 6 2011 e23905
22. R. van Doorn, and et al. Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier J. Neuroinflamm. 9 2012 133
23. T. Walzer, and et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor Nat. Immunol. 8 2007 1337 1344
24. N. Czeloth, and et al. Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen J. Immunol. 179 2007 5855 5863
25. S.Y. Xiang, and et al. Lysophospholipid receptor activation of RhoA and lipid signaling pathways Biochim. Biophys. Acta 1831 2013 213 222
26. M. Maceyka, and et al. Sphingosine-1-phosphate signaling and its role in disease Trends Cell Biol. 22 2012 50 60
27. N.J. Pyne, and et al. Sphingosine 1-phosphate signalling in cancer Biochem. Soc. Trans. 40 2012 94 100
28. M. Maceyka, and S. Spiegel Sphingolipid metabolites in inflammatory disease Nature 510 2014 58 67
29. J.C. Mudd, and et al. Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes Blood 121 2013 2914 2922
30. A.L. St John, and et al. S1P-dependent trafficking of intracellular Yersinia pestis through lymph nodes establishes buboes and systemic infection Immunity 41 2014 440 450
31. M.R. Dominguez, and et al. Re-circulation of lymphocytes mediated by sphingosine-1-phosphate receptor-1 contributes to resistance against experimental infection with the protozoan parasite Trypanosoma cruzi Vaccine 30 2012 2882 2891
32. G. Zhang, and et al. Differences in membrane association and sub-cellular distribution between NS2-3 and NS3 of bovine viral diarrhoea virus Virus Res. 97 2003 89 102
33. D. Yamane, and et al. Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis J. Biol. Chem. 284 2009 13648 13659
34. S. Wati, and et al. Tumour necrosis factor alpha (TNF-alpha) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-alpha to activate nuclear factor kappaB and reduced sphingosine kinase-1 activity J. Gen. Virol. 92 2011 807 818
35. S.E. Alvarez, and et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 Nature 465 2010 1084 1088
36. J.M. Carr, and et al. Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3′ untranslated region of dengue virus type-2 RNA J. Gen. Virol. 94 2013 2437 2448
37. N.J. Machesky, and et al. Human cytomegalovirus regulates bioactive sphingolipids J. Biol. Chem. 283 2008 26148 26160
38. Y.J. Seo, and et al. Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection PLOS ONE 8 2013 e75005
39. M. Vijayan, and et al. Sphingosine kinase 1 regulates measles virus replication Virology 450-451 2014 55 63
40. M.M. Monick, and et al. Sphingosine kinase mediates activation of extracellular signal-related kinase and Akt by respiratory syncytial virus Am. J. Respir. Cell Mol. Biol. 30 2004 844 852
41. Y.J. Seo, and et al. Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity J. Virol. 84 2010 8124 8131
42. S. Tong, and et al. H9N2 avian influenza infection altered expression pattern of Sphiogosine-1-phosphate Receptor 1 in BALB/c mice Virol. J. 10 2013 296
43. J.R. Teijaro, and et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection Cell 146 2011 980 991
44. D. Marsolais, and et al. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection Proc. Natl. Acad. Sci. U. S. A. 106 2009 1560 1565
45. D. Marsolais, and et al. Local not systemic modulation of dendritic cell S1P receptors in lung blunts virus-specific immune responses to influenza Mol. Pharmacol. 74 2008 896 903
46. Z. Wang, and et al. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides J. Immunol. 188 2012 345 357
47. S.K. Garg, and et al. Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo J. Infect. Dis. 189 2004 2129 2138
48. S.K. Garg, and et al. Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? Clin. Immunol. 121 2006 260 264
49. + T cells in Mycobacterium tuberculosis-infected monocytes Biochem. Biophys. Res. Commun. 361 2007 687 693
50. P. Mendez-Samperio, and et al. Sphingosine kinase, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 are required for CCL5 production in Mycobacterium bovis Bacillus Calmette-Guerin (BCG)-infected epithelial cells Cell. Immunol. 249 2007 94 100
51. B. Vesosky, and et al. CCL5 participates in early protection against Mycobacterium tuberculosis J. Leukoc. Biol. 87 2010 1153 1165
52. 2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase J. Immunol. 170 2003 2811 2815
53. J.M. Richmond, and et al. Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis preferentially inhibits sphingosine-1-phosphate-induced migration of Th1 cells J. Immunol. 189 2012 5886 5895
54. H. Prakash, and et al. Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages PLoS ONE 5 2010 e10657
55. M. Yadav, and et al. Macrophage's proinflammatory response to a mycobacterial infection is dependent on sphingosine kinase-mediated activation of phosphatidylinositol phospholipase C, protein kinase C, ERK1/2, and phosphatidylinositol 3-kinase J. Immunol. 176 2006 5494 5503
56. S. Ochi, and et al. Clostridium perfringens alpha-toxin activates the sphingomyelin metabolism system in sheep erythrocytes J. Biol. Chem. 279 2004 12181 12189
57. A. Oizumi, and et al. Pseudomonas-derived ceramidase induces production of inflammatory mediators from human keratinocytes via sphingosine-1-phosphate PLOS ONE 9 2014 e89402
58. A. Rub, and et al. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function Nat. Immunol. 10 2009 273 280
59. S. Majumder, and et al. Leishmania-induced biphasic ceramide generation in macrophages is crucial for uptake and survival of the parasite J. Infect. Dis. 205 2012 1607 1616
60. A. Rub, and et al. Host-lipidome as a potential target of protozoan parasites Microbes Infect. 15 2013 649 660
61. A. Lepletier, and et al. Early double-negative thymocyte export in Trypanosoma cruzi infection is restricted by sphingosine receptors and associated with human Chagas disease PLoS Negl. Trop. Dis. 8 2014 e3203
62. C.A. Finney, and et al. S1P is associated with protection in human and experimental cerebral malaria Mol. Med. 17 2011 717 725
63. O. Zhang, and et al. Sphingosine kinase A is a pleiotropic and essential enzyme for Leishmania survival and virulence Mol. Microbiol. 90 2013 489 501
64. T. McQuiston, and et al. Role of host sphingosine kinase 1 in the lung response against Cryptococcosis Infect. Immun. 78 2010 2342 2352
65. T. McQuiston, and et al. Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages Microbiology 157 2011 1416 1427
66. V. Brinkmann, and et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors J. Biol. Chem. 277 2002 21453 21457
67. K. LaMontagne, and et al. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization Cancer Res. 66 2006 221 231
68. L. Wang, and et al. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury Crit. Care Med. 42 2014 e189 e199
69. M.L. Oo, and et al. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor J. Biol. Chem. 282 2007 9082 9089
70. D.D. Pinschewer, and et al. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory J. Immunol. 164 2000 5761 5770
71. + regulators J. Immunol. 180 2008 7636 7647
72. M.H. Graler The role of sphingosine 1-phosphate in immunity and sepsis Am. J. Clin. Exp. Immunol. 1 2012 90 100
73. C. Lundblad, and et al. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat Acta Anaesthesiol. Scand. 57 2013 713 718
74. Y. Pewzner-Jung, and et al. Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa EMBO Mol. Med. 6 2014 1205 1214
75. R.A. McDonald, and et al. The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia Br. J. Pharmacol. 159 2010 543 553
76. Y.J. Seo, and et al. Sphingosine analogue AAL-R increases TLR7-mediated dendritic cell responses via p38 and type I IFN signaling pathways J. Immunol. 188 2012 4759 4768
77. M.P. Matheu, and et al. Three phases of CD8T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy PLOS ONE 8 2013 e58033
78. M.B. Oldstone, and et al. Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection Virology 435 2013 92 101
79. Y.J. Seo, and B. Hahm Sphingosine analog AAL-R promotes activation of LCMV-infected dendritic cells Viral Immunol. 27 2014 82 86
80. C. Skerry, and et al. Sphingosine-1-phosphate receptor agonism reduces Bordetella pertussis-mediated lung pathology J. Infect. Dis. 211 2014 1883 1886
81. L. Yang, and et al. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo Biochem. Biophys. Res. Commun. 460 2015 903 908
82. R.A. Sabbadini Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration Br. J. Pharmacol. 162 2011 1225 1238
83. B. Visentin, and et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages Cancer Cell 9 2006 225 238
84. A. Rana, and et al. A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases Virulence 6 2015 566 580